SCHEMBL9236650

SCHEMBL9236650

N#CCC(=O)Nc1ccc2c(c1)Cc1cc(I)ccc1-2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.56
▸ POLB P06746 1/20 0.55
▸ AAK1 Q2M2I8 2/20 0.50
▸ NPC1 O15118 1/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ SLC1A3 P43003 6/20 0.44
▸ SLC1A2 P43004 6/20 0.44
▸ SLC1A1 P43005 6/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ HTR2B P41595 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9206404 0.78 CA12 (0.63) POLBKMT2ACYP1A2CYP2C19CA12
SCHEMBL4380156 0.77 MAOA (0.70) RAB9APOLBNPC1KMT2ACYP1A2
SCHEMBL6314665 0.76 NPC1 (0.59) RAB9APOLBNPC1KMT2ACYP1A2
SCHEMBL14517868 0.76 HSD17B10 (0.59) KMT2ACYP1A2CYP2C19CA12CA1
SCHEMBL11122026 0.73 CA12 (0.73) POLBAAK1KMT2ACYP1A2CYP2C19
SCHEMBL9238594 0.72 DHODH (0.57) RAB9APOLBNPC1KMT2ACYP1A2
SCHEMBL21765666 0.72 RAB9A (0.71) RAB9APOLBNPC1KMT2ACYP1A2
SCHEMBL21765857 0.72 RAB9A (1.00) RAB9APOLBAAK1NPC1KMT2A
SCHEMBL10917830 0.70 KDM4E (0.63) POLBKMT2ACYP1A2CYP2C19MEN1
SCHEMBL23518441 0.69 RAB9A (0.69) RAB9APOLBAAK1NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0652214-A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1995-05-10 — — EP disclosed
Send feedback